BrainScope Completes Trials Of Brain Injury Assessment In Collaboration With US DOD, NFL, GE
Executive Summary
Investigators have completed the algorithm development and clinical validation studies of objective, electroencephalogram-based technology in adolescent and young adult populations, the company says. The studies were funded by a $9.9m research contract from the US Department of Defense, award funding from the National Football League-GE Head Health Challenge, and BrainScope.
You may also be interested in...
BrainScope’s Head Injury Assessment Device Moves Closer To Military, Sports Use
BrainScope received 510(k) clearance in May for Ahead 200, a second-generation, handheld, noninvasive device for the adjunctive assessment of traumatic brain injury in adults over 18 years of age. With an estimated 60 million cases of TBI annually worldwide, the company is initially focusing on military and sports applications, but is also looking at emerging markets such as India and China, where there are fewer CT scanners and the rate of head injury is substantially higher than in the US.
News We’re Watching: FDA Approves Medtronic's Affera, Roche's CGM Moves Closer To Approval, And More
Medtech Insight's News We're Watching covers medtech industry and research news you may have missed. This week, the Advanced Technologies and Treatments for Diabetes (ATTD) conference in Florence, Italy, included new results from studies of Roche's continuous glucose monitor and Medtronic's 780G insulin pump, Medtronic moved closer to earning FDA approval for its Affera ablation mapping and ablation system, and Linus Health expanded its technology for finding signs of cognitive problems in speech data.
New’s We’re Watching: J&J's Varipulse PFA Earns CE Mark; Labs Create Intravascular Robots; And More
Medtech Insight's News We're Watching highlights some recent business and R&D developments you may have missed. This week, Biosense Webster’s Varipulse PFA platform earned a CE mark; Biosense Webster also announced the start the pivotal IDE study of its Laminar left atrial appendage elimination system; the FDA approved Boston Scientific's Agent paclitaxel-coated balloon and cleared Medtronic's OsteoCool 2.0 bone ablation system; three papers in Science Robotics describe magnetically controlled vascular robots that could go places wires and catheters cannot.